학술논문
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
Document Type
Article
Author
Clarke, N.W. ; Ali, A.; Ingleby, F.C.; Hoyle, A.; Amos, C.L.; Attard, G.; Brawley, C.D.; Calvert, J.; Chowdhury, S.; Cook, A.; Cross, W.; Dearnaley, D.P.; Douis, H.; Gilbert, D.; Gillessen, S.; Jones, R.J.; Langley, R.E.; MacNair, A.; Malik, Z.; Mason, M.D.; Matheson, D.; Millman, R.; Parker, C.C.; Ritchie, A.W.S.; Rush, H.; Russell, J.M.; Brown, J.; Beesley, S.; Birtle, A.; Capaldi, L.; Gale, J.; Gibbs, S.; Lydon, A.; Nikapota, A.; Omlin, A.; O'Sullivan, J.M.; Parikh, O.; Protheroe, A.; Rudman, S.; Srihari, N.N.; Simms, M.; Tanguay, J.S.; Tolan, S.; Wagstaff, J.; Wallace, J.; Wylie, J.; Zarkar, A.; Sydes, M.R.; Parmar, M.K.B.; James, N.D.
Source
In Annals of Oncology December 2019 30(12):1992-2003
Subject
Language
ISSN
0923-7534